Lupin informs about updates

20 Sep 2025 Evaluate

Lupin has informed that the U.S. FDA has conducted a product-specific Pre-Approval Inspection at the Company’s Pune Biotech facility from September 08 to September 19, 2025. The inspection closed with four observations. The company will address the observations and respond to the U.S. FDA within the stipulated timeframe. The company is committed to be compliant with CGMP quality standards across all its facilities.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2312.70 -22.25 (-0.95%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×